Foscarnet and ganciclovir combination therapy for CMV disease in HIV-infected patients
✍ Scribed by B. Salzberger; G. Fätkenheuer; A. Schwenk; C. Franzen; O. Cornely; M. Schrappe; A. Stoehr; W. Heise
- Publisher
- Springer-Verlag
- Year
- 1994
- Tongue
- English
- Weight
- 678 KB
- Volume
- 22
- Category
- Article
- ISSN
- 0300-8126
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract In HIV‐infected patients treated with highly active antiretroviral therapy (HAART) included in the Predivir cohort, we have evaluated the usefulness of CMV DNA quantitation by a TaqMan^®^ PCR assay from peripheral blood leukocytes (PBLs) to predict CMV disease occurrence. In parallel wi
## Abstract Cell‐free human immunodeficiency virus type‐I (HIV‐1) was precipitated from archival serum with polyethylene glycol (PEG), and HIV‐1 RNA was detected and quantified by reverse transcription and amplification in a nested polymerase chain reaction (PCR). The assay of endpoint dilutions cD